FIELD: medicine; urology; therapy; functional diagnostics and physiotherapy.
SUBSTANCE: invention can be used for combined non-invasive treatment of detrusor hyperactivity in patients after transurethral resection of the prostate. Mirabegron is administered orally at a dose of 50 mg per day for 1 month. Simultaneously with taking Mirabegron, extracorporeal magnetic stimulation of the neuromuscular apparatus of the pelvic floor and small pelvic organs is carried out with the help of an apparatus for extracorporeal magnetic simulation with a pulse frequency of at least 10 Hz, a magnetic field strength of 0.5 Tl. Extracorporeal magnetic stimulation is carried out 3 times a week. The course of treatment is 10–12 procedures.
EFFECT: method provides an increase in the effectiveness of the treatment of detrusor hyperactivity.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF OVERACTIVE BLADDER SYNDROME | 2022 |
|
RU2792534C1 |
| METHOD OF COMBINED NON-INVASIVE TREATMENT OF URINARY INCONTINENCE IN PATIENTS AFTER RADICAL PROSTATECTOMY | 2018 |
|
RU2708490C2 |
| TREATMENT METHOD OF A HYPERACTIVE URINARY BUBBLE | 2017 |
|
RU2644304C1 |
| METHOD OF TREATING THE NEUROGENIC BLADDER | 2020 |
|
RU2743805C1 |
| METHOD FOR MEDICAL REHABILITATION OF PATIENTS FOLLOWING ISCHEMIC STROKE (IS) WITH ACCOMPANYING URINATION DISORDERS | 2020 |
|
RU2734335C1 |
| METHOD OF TREATING BLADDER HYPOTENSION WITH USING ADIPOSE MESENCHYMAL STEM CELLS | 2019 |
|
RU2712029C1 |
| METHOD OF TREATING NEUROGENIC BLADDER DYSFUNCTION MANIFESTED BY FUNCTIONAL INFRAVESICAL OBSTRUCTION IN FEMALES | 2019 |
|
RU2721300C2 |
| METHOD OF TREATING CHILDREN SUFFERING NEUROGENIC BLADDER DYSFUNCTION WITH DECREASED URINATE ACTIVITY BY BIOLOGICAL FEEDBACK | 2010 |
|
RU2452531C1 |
| METHOD OF TREATING CHILDREN WITH OVERACTIVE BLADDER | 2014 |
|
RU2585727C1 |
| METHOD OF MEDICAL REHABILITATION OF CHILDREN WITH DYSFUNCTION OF THE PELVIC ORGANS | 2022 |
|
RU2798961C1 |
